Combining alcohol use disorder treatments with liver disease care
Official title: Integrating Treatments for Alcohol Use Disorder into Hepatology Clinics
Funded at Yale University · NIH-10928796 · Data updated 2026-11-12
This study is looking at the best ways to help people with alcohol use problems who also have liver disease by finding effective treatments in liver clinics, making sure patients feel comfortable and supported.
Quick facts
| Grant type | NIH-funded research |
|---|---|
| Study type | NIH-funded research |
| Funding institution | Yale University NIH-funded |
| Lab location | 1 site (New Haven, United States) |
| Project start | September 13, 2023 |
| Project end | August 31, 2027 |
| Funding year | 2024 |
| Award (this year) | $194,267 |
| NIH project number | 5K23AA031334-02 |
| Project ID | NIH-10928796 on NIH RePORTER |
Who could benefit from this research
✓Could help
Ideal candidates for this research are individuals diagnosed with both alcohol use disorder and alcohol-associated liver disease.
✕Less likely to help
Patients who do not have alcohol use disorder or alcohol-associated liver disease may not benefit from this research.
What this research studies
This research investigates how to effectively integrate treatments for alcohol use disorder (AUD) into hepatology clinics, where patients with alcohol-associated liver disease (ALD) are treated. It aims to identify the best methods for delivering behavioral therapies and medications to patients suffering from both AUD and ALD, addressing barriers such as stigma and lack of familiarity among clinicians. By focusing on the perspectives of patients, the research seeks to improve treatment uptake and outcomes for this vulnerable population.
Why it matters
Potential benefit: If successful, this research could lead to improved treatment options and outcomes for patients with alcohol use disorder and liver disease.
How similar studies have gone: Previous research has shown that integrated treatment approaches can be effective, but this specific model is relatively novel and untested.
Where this research is happening
-
Yale University
New Haven, United States Active
Researchers
- Principal investigator: Haque, Lamia — Yale University
- Study coordinator: Haque, Lamia
Related research
Other NIH-funded projects on the same topics.
-
Functional Connectivity-Guided TMS for Alcohol Use Disorder
A new approach uses targeted brain stimulation to help people with alcohol use disorder stay abstinent longer by focusing treatment on specific brain circuits.
-
Alcohol Use Disorder and Suicidal Behavior: Finding Why They Occur Together
A study using Swedish population data to understand why alcohol use disorder relates to suicidal thoughts and acts, with the goal of improving risk prediction and prevention.
-
Non-hallucinogenic psilocybin derivative for alcohol use disorder
A new, safer psilocybin-like compound is being studied to help people with alcohol use disorder.
-
Identifying brain proteins linked to PTSD and alcohol use disorder
Researchers are studying brain proteins that may contribute to PTSD and alcohol use disorder in US veterans to find new ways to help people who struggle with both conditions.
-
Mu and Kappa Opioid Balance in Alcohol Use Disorder
A study using brain imaging to understand how the brain’s opioid system changes during early sobriety in adults with alcohol use disorder.
-
Telehealth support to prevent suicide in people with alcohol use disorder in Tanzania
A telehealth counseling program is being adapted to help reduce suicide risk for people with alcohol use disorder in emergency departments in Tanzania.
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page.